A new study published in the Proceedings of the National Academy of Sciences reports on the discovery of a new cancer gene. The cancer caused by this newly discovered gene is called adenoid cystic carcinoma and is usually found in the head and neck, but it is also one form of breast cancer.
This new breast cancer gene is a 'fusion gene', meaning that it is the combination of two other genes. The two genes involved are called MYB and NFIB. According to the study SUMMARY, the fusion of these two genes results in the activation of MYB, which is involved in cell cycle control, cell growth, blood vessel growth, and cell adhesion. The researchers indicated that this fusion gene is a defining characteristic of adenoid cystic carcinoma and that deregulation of MYB is a key step in the initiation of this type of breast cancer.
This could be truly important, ground breaking research. If as the study investigators indicated, this fusion gene is present in all of these types of cancers, including breast caner, then this gene becomes an excellent target for new forms of breast cancer therapy. While it will likely be some time before this new breast cancer research news is translated into new forms of breast cancer therapy, this is excellent news for the future.
While total breast cancer prevention is the ultimate goal, there are steps that you can take right now to reduce your breast caner risk. To learn more read my book Fight Now: Eat & Live Proactively Against Breast Cancer at www.fightBCnow.com.